Vantage logo

Amylyx faces an uphill battle

Briefing documents show why the FDA should await more data on the ALS project, but will it bow to patient pressure?

Vantage logo

A radical strategy for Medtronic

The sellside expects the world’s leading medtech to be outpaced by its rivals. Divestments might allow the group to defy this destiny.